Quantrx Biomedical Corporation (QTXB)
Market Closed
8 Apr, 20:00
OTC PINK OTC PINK Primary $
0. 00
+0
+400%
$
118.05K Market Cap
- P/E Ratio
- Div Yield
22,100 Volume
0 Eps
$ 0
Previous Close Want to track QTXB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
QTXB closed Tuesday higher at $0, an increase of 400% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, QTXB stock gained 0%.
QTXB is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, missed the consensus estimates by -0.0056%. On average, the company has fell short of earnings expectations by -0.0029%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
Quantrx Biomedical Corporation (QTXB) FAQ
What is the stock price today?
The current price is $0.00.
On which exchange is it traded?
Quantrx Biomedical Corporation is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is QTXB.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 118.05K.
Has Quantrx Biomedical Corporation ever had a stock split?
No, there has never been a stock split.
Quantrx Biomedical Corporation Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Shalom Z. Hirschman CEO | OTC PINK Exchange | 74765N109 CUSIP |
| US Country | - Employees | - Last Dividend | - Last Split | 31 May 1988 IPO Date |
QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.
Contact Information
Address: 10190 SW 90th Avenue
Phone: 212 980 2235
Website: https://www.quantrx.com/index.htm
